Frega A, di Renzi F, Stentella P, Pachì A
II Clinic of Obstetrics and Gynecology, University of Rome La Sapienza, Italy.
Int J Gynaecol Obstet. 1994 Mar;44(3):255-8. doi: 10.1016/0020-7292(94)90175-9.
To evaluate the effect of a combined therapy based on beta-interferon and thymostimulin in HIV-seropositive women with florid vulvoperineal condylomatosis.
Nineteen HIV-seropositive women affected by HPV florid vulvo-perineal infection were studied. Their ages ranged from 19 to 32 years (mean = 26); all were smokers; 11 (57.89%) were intravenous drug users with a mean period of drug addiction of 5 years. No patient was on AZT therapy. All patients underwent a combined medical therapy based on beta-interferon administration with doses of 3,000,000 IU i.m. daily for 7 days and subsequently on alternate days for 2 weeks associated with the administration of 70 mg i.m. of thymostimulin per day on alternate days for 30 days.
Seven (36.84%) patients showed complete recovery at the end of follow-up; 5 (26.31%) patients showed partial recovery and 7 (36.84%) did not respond to therapy.
A pro-host immunotherapy seems to be indicated in patients affected by immunodeficiency syndrome.
评估基于β-干扰素和胸腺刺激素的联合疗法对患有严重外阴尖锐湿疣的HIV血清阳性女性的疗效。
对19名受HPV严重外阴-会阴感染影响的HIV血清阳性女性进行了研究。她们的年龄在19至32岁之间(平均26岁);均为吸烟者;11名(57.89%)为静脉吸毒者,平均吸毒时间为5年。无患者接受齐多夫定治疗。所有患者均接受了联合药物治疗,即每天肌肉注射300万国际单位的β-干扰素,连续7天,随后隔日注射2周,并隔日肌肉注射70毫克胸腺刺激素,共30天。
7名(36.84%)患者在随访结束时完全康复;5名(26.31%)患者部分康复,7名(36.84%)患者对治疗无反应。
对于受免疫缺陷综合征影响的患者,似乎需要进行促进宿主免疫疗法。